Lopez-Olivo, M
Some clinicians treat "indefinitely" (i.e., long-term) as long as the drug remains safe for the patient and effective
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unlicensed by the MHRA or EMA and still being evaluated in Phase 2 and Phase 3 clinical trials
The biological functions of stromal cell-derived factors 1 and 1 (SDF-1 and SDF- 1, CXCL12), macrophage-derived chemokine (MDC, CCL22), interferon-inducible T cell -chemoattractant (ITAC, CXCL11), inflammatory protein-10 (IP10, CXCL10), monokine-induced by gamma interferon (MIG, CXCL9), eotaxin (CCL11), granulocyte chemotactic protein 2 (GCP2, CXCL6), and Gro (CXCL2) have been shown to be substrates for proteolytic modification by DPP4
Clin Cancer Investig J
In a class action, courts typically determine damages (monetary awards) on a collective basis